www.fdanews.com/articles/138848-court-affirms-lilly-rsquo-s-strattera-patent
Court Affirms Lilly’s Strattera Patent
August 1, 2011
The Federal Circuit on Friday upheld the validity of drugmaker Eli Lilly’s patent for attention deficit hyperactivity disorder drug Strattera, dealing a blow to Actavis Elizabeth, Apotex and other generic-drug makers who had hoped to market a version of the drug.
Law360
Law360